بيكالوتاميد تيڤع ٥٠ ملغ
teva pharmaceutical indust.ltd - bicalutamide 50 mg - tablets - bicalutamide - for the treatment of advanced prostate cancer in combination with lhrh analog therapy or surgical castration.
بيكالوتاميد تيڤع ١٥٠ ملغ
teva pharmaceutical indust.ltd - bicalutamide 150 mg - tablets - bicalutamide - in patients with locally advanced prostate cancer (t3-t4 any n m0 t1-t2 n+ m0) bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.
lamotrigina tevagen 100mg 56 comprim dispers efg
lamotrigina tevagen 200mg 30 comprim dispersab efg
lamotrigina tevagen 50mg 56 comprim dispersa efg
ebastina tevagen 10mg 20 comprimidos recubiertos pelicula efg